These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1671730)

  • 1. Immune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadone.
    Klimas NG; Blaney NT; Morgan RO; Chitwood D; Milles K; Lee H; Fletcher MA
    Am J Med; 1991 Feb; 90(2):163-70. PubMed ID: 1671730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic assessment of a cluster of asymptomatic HTLV-I-infected individuals in New Orleans.
    deShazo RD; Chadha N; Morgan JE; Shorty VJ; Rangan SR; Kalyanaraman VS; Hyslop N; Chapman Y; O'Dea S
    Am J Med; 1989 Jan; 86(1):65-70. PubMed ID: 2521277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of retroviral infections on immune function in African-American intravenous drug users.
    Klimas NG; Page JB; Patarca R; Chitwood D; Morgan R; Fletcher MA
    AIDS; 1993 Mar; 7(3):331-5. PubMed ID: 8471194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of methadone on immunological parameters among HIV-positive and HIV-negative drug users.
    Carballo-Diéguez A; Sahs J; Goetz R; el Sadr W; Sorell S; Gorman J
    Am J Drug Alcohol Abuse; 1994 Aug; 20(3):317-29. PubMed ID: 7977217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune function and drug treatment in anti-retrovirus negative intravenous drug users.
    Fletcher MA; Klimas NG; Morgan RO
    Adv Exp Med Biol; 1993; 335():241-6. PubMed ID: 8237601
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
    Novick DM; Ochshorn M; Ghali V; Croxson TS; Mercer WD; Chiorazzi N; Kreek MJ
    J Pharmacol Exp Ther; 1989 Aug; 250(2):606-10. PubMed ID: 2788218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of immune activation with intravenous heroin use and methadone treatment in HIV-1 seropositive and seronegative subjects.
    Di Franco MJ; Marlink R; Hunter DJ; Tosteson T; Mayer K; Essex M
    J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1297-300. PubMed ID: 8254465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic abnormalities related to antigenaemia during HIV-1 infection.
    De Paoli P; Battistin S; Crovatto M; Modolo ML; Carbone A; Tirelli U; Santini G
    Clin Exp Immunol; 1988 Dec; 74(3):317-20. PubMed ID: 2976619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant augmentation of CD4+ CD29+ helper inducer and diminution of CD4+ CD45RA+ suppressor inducer subset in patients infected with human T cell lymphotropic virus types I or II.
    Lal RB; Rudolph DL; Schmid DS; Lairmore MD
    Clin Exp Immunol; 1992 Feb; 87(2):293-7. PubMed ID: 1370929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection.
    Margolick JB; Muñoz A; Vlahov D; Solomon L; Astemborski J; Cohn S; Nelson KE
    JAMA; 1992 Mar; 267(12):1631-6. PubMed ID: 1347321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sectional study of immunologic abnormalities in intravenous drug abusers on methadone maintenance in New York City.
    Grieco MH; Reddy MM; Fusillo CA; Sorrell SJ; Buimovici-Klein E; Gindi EJ; Brown DK; Saxinger WC; Weiss SH; Flaster ER
    AIDS; 1989 Apr; 3(4):235-7. PubMed ID: 2500957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No seroconversions among steady sex partners of methadone-maintained HIV-1-seropositive injecting drug users in New York City.
    Siddiqui NS; Brown LS; Phillips RY; Vargas O; Makuch RW
    AIDS; 1992 Dec; 6(12):1529-33. PubMed ID: 1492936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in immune and psychological measures as a function of anticipation and reaction to news of HIV-1 antibody status.
    Ironson G; LaPerriere A; Antoni M; O'Hearn P; Schneiderman N; Klimas N; Fletcher MA
    Psychosom Med; 1990; 52(3):247-70. PubMed ID: 1973303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway.
    Hofmann B; Jakobsen KD; Odum N; Dickmeiss E; Platz P; Ryder LP; Pedersen C; Mathiesen L; Bygbjerg IB; Faber V
    J Immunol; 1989 Mar; 142(6):1874-80. PubMed ID: 2564029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users.
    Gourevitch MN; Selwyn PA; Davenny K; Buono D; Schoenbaum EE; Klein RS; Friedland GH
    Ann Intern Med; 1993 Mar; 118(5):350-5. PubMed ID: 8094280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term changes in psychological symptomatology associated with HIV serostatus among male injecting drug users.
    Davis RF; Metzger DS; Meyers K; McLellan AT; Mulvaney FD; Navaline HA; Woody GE
    AIDS; 1995 Jan; 9(1):73-9. PubMed ID: 7893444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte subsets and natural killer cell cytotoxicity in intravenous drug users with HIV-1 infection among Thai population.
    Kantakamalakul W; Jangkhum S; Ampol S; Burupharat P; Chuachoowong R; Sutthent R; Pattanapanyasat K
    Asian Pac J Allergy Immunol; 2019 Mar; 37(1):51-56. PubMed ID: 29549702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program.
    Selwyn PA; Budner NS; Wasserman WC; Arno PS
    Public Health Rep; 1993; 108(4):492-500. PubMed ID: 8393579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV-1 seroprevalence in AIDS patients and in HIV-1 seropositive and seronegative subjects at risk for AIDS in northern Italy.
    Manca N; Caruso A; Bonfanti C; Savoldi E; Li Vigni R; Pirali F; Sapelli PL; Turano A
    Eur J Epidemiol; 1989 Mar; 5(1):37-41. PubMed ID: 2707393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic, immunologic, and clinical features of parenteral drug users from contrasting populations.
    Shine D; Moll B; Emeson E; Spigland I; Harris C; Small CB; Friedland G; Weiss SH; Bodner AJ
    Am J Drug Alcohol Abuse; 1987; 13(4):401-12. PubMed ID: 2961253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.